Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 14, 2008. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically detailing changes in their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding insider trading activity rather than a financial performance report.
Material Changes
The material change reported is the purchase of Ordinary Shares by three individuals on January 10, 2008, under a Single Company ISA at a price of GBP 13.85 per share. The individuals and their respective share purchases are:
- Mr E J Gray: 5 shares
- Mr J S Heslop: 5 shares
- Mr A P Witty: 5 shares
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The transaction was notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the total number of shares purchased by the named directors (5 shares each).
- Confirm the transaction price of GBP 13.85 per Ordinary Share.
- Note the transaction date of January 10, 2008, and the notification date of January 11, 2008.
- Confirm that this filing does not contain financial performance data for the period.